Doom or Bloom?, page-5

Salient points IMO Lazarus, except the valuation. If Sieg is being truthful about near commercialisation- then 0.2 us cheap, if not then any price is too much.

If one missed the chance to sell at 0.5 then I'd suggets there is little reason to sell now, and until a more solid announcement with a date or name on it comes; little reason to buy. It is somewhat promising that Sieg is starting to put dates in the Anns though (meeting in 1 week with Hallmark, payment from Lanstead, testing results by end of October).

Accountable results to wait makes a much easier decision.